wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52684522-34B2B3FF-F3B7-4102-8F6D-D54AC572D8E9
Q52684522-34B2B3FF-F3B7-4102-8F6D-D54AC572D8E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52684522-34B2B3FF-F3B7-4102-8F6D-D54AC572D8E9
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase II study.
P2860
Q52684522-34B2B3FF-F3B7-4102-8F6D-D54AC572D8E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52684522-34B2B3FF-F3B7-4102-8F6D-D54AC572D8E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5b971ef50bbb64585da0e937698e4f1ff35b41c1
P2860
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.